Network origin in Scott M. Storer first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 9 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Scott M. Storer via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer Private Equity Analyst | |
| IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| The Medical College of Wisconsin, Inc. | College/University | Corporate Officer/Principal | |
| MARINUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Director/Board Member | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| EISAI CO., LTD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Hospital Clínic de Barcelona
 Hospital Clínic de Barcelona Hospital/Nursing ManagementHealth Services Hospital Clínic de Barcelona is a healthcare company based in Barcelona, Spain. The Spanish company operates a website for Hospital Clínic and IDIBAPS. The CEO of the private company is Josep Maria Campistol. | Hospital/Nursing Management | Corporate Officer/Principal | |
Boston Pharmaceuticals, Inc.
 Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| BICYCLE THERAPEUTICS PLC | Biotechnology | Corporate Officer/Principal | |
| University of Barcelona | College/University | Doctorate Degree | |
| Universidad Autónoma de Madrid | College/University | Doctorate Degree | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Kellogg School of Management | College/University | Masters Business Admin | |
| University of Michigan | College/University | Undergraduate Degree | |
| FULCRUM THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| GENOCEA BIOSCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
GlycoEra AG
 GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | Biotechnology | Director/Board Member | |
| EDITAS MEDICINE, INC. | Biotechnology | Director of Finance/CFO | |
| Massachusetts Institute of Technology | College/University | Masters Business Admin | |
| Brandeis University | College/University | Doctorate Degree | |
| TSCAN THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
| GERON CORPORATION | Biotechnology | Director of Finance/CFO | |
| VERASTEM, INC. | Biotechnology | Director/Board Member | |
| Bentley University | College/University | Undergraduate Degree | |
| BAXALTA INC | Biotechnology | Corporate Officer/Principal | |
Bioverativ Therapeutics, Inc.
 Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Pharmaceuticals: Major | President | |
| FORTE BIOSCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| ARCELLX, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| AIMMUNE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| UCLA Anderson School of Management | College/University | Masters Business Admin | |
University of Houston
 University of Houston Other Consumer ServicesConsumer Services University of Houston System offers higher education degrees and job training or vocational study programs. It offers about 280 undergraduate and graduate degree programs in fields such as business, education, humanities and law. It was founded in 1927 and is headquartered in Houston, TX. | College/University | Graduate Degree | |
| Indian Institute of Technology New Delhi | College/University | Graduate Degree | |
| VOYAGER THERAPEUTICS, INC. | Biotechnology | Chief Operating Officer | |
Massachusetts Bar Association
 Massachusetts Bar Association Miscellaneous Commercial ServicesCommercial Services The Massachusetts Bar Association is a non-profit organization that serves the legal profession and the public by promoting the administration of justice, legal education, professional excellence, and respect for the law. The MBA is based in Boston, MA. The organization offers various membership advantages, volunteer opportunities, and educational resources such as CLE programs, practicing with professionalism courses, and publications like the ejournal and Lawyers Journal. The MBA also provides advocacy services, public resources, and exclusive benefits to its members such as the Lawyer Referral Service, Insurance Agency, and MBA On Demand. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Science Club For Girls | Director/Board Member | ||
| CYCLERION THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director of Finance/CFO | |
| SYNDAX PHARMACEUTICALS, INC. | Biotechnology | Director of Finance/CFO | |
| Princeton University | College/University | Undergraduate Degree | |
| Boston University | College/University | Masters Business Admin | |
| FORMA THERAPEUTICS HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| The Schwartz Center for Compassionate Healthcare | Director/Board Member | ||
Synlogic Operating Co., Inc.
 Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
| SYROS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
FORMA Therapeutics, Inc.
 FORMA Therapeutics, Inc. BiotechnologyHealth Technology FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA. | Biotechnology | Director/Board Member | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| West Virginia University | College/University | Undergraduate Degree |
Statistics
International
| United States | 42 |
| Spain | 4 |
| Denmark | 2 |
| Japan | 2 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 31 |
| Consumer Services | 14 |
| Commercial Services | 4 |
| Health Services | 2 |
| Finance | 2 |
Operational
| Corporate Officer/Principal | 22 |
| Director/Board Member | 17 |
| Chief Tech/Sci/R&D Officer | 15 |
| Independent Dir/Board Member | 12 |
| Director of Finance/CFO | 8 |
Most connected contacts
| Insiders | |
|---|---|
| Santiago Arroyo | 14 |
| Marsha Fanucci | 13 |
| James M. Roach | 11 |
| Alejandra Carvajal | 10 |
| Richard Shea | 9 |
| Narinder Singh | 8 |
| Michelle Robertson | 7 |
| Matthew P. Ottmer | 6 |
| William Desmarais | 5 |
- Stock Market
- Insiders
- Scott M. Storer
- Company connections
